Pulmonary Embolism (PE) is responsible for high rates of death and hospitalisation globally [ ] and yet the core clinical problem leading to death - increased right ventricular afterload due to pulmonary arterial obstruction - should be, at first glance, a relatively straightforward bioengineering problem to solve.